Protein binding of theophylline.
作者信息
Buss D C, Ebden P, Baker S, Routledge P A
出版信息
Br J Clin Pharmacol. 1985 Apr;19(4):529-31. doi: 10.1111/j.1365-2125.1985.tb02684.x.
Abstract
摘要
相似文献
1
Protein binding of theophylline.茶碱的蛋白质结合
Br J Clin Pharmacol. 1985 Apr;19(4):529-31. doi: 10.1111/j.1365-2125.1985.tb02684.x.
2
[Serum theophylline levels in chronic obstructive pulmonary disease patients receiving uniphyllin].[接受优喘平治疗的慢性阻塞性肺疾病患者的血清茶碱水平]
Zhonghua Yi Xue Za Zhi (Taipei). 1988 Jan;41(1):37-42.
3
[Microcrystallinic theophylline, plasma concentration and adverse effects in patients with obstructive lung disease].[微晶型茶碱、阻塞性肺疾病患者的血浆浓度及不良反应]
Tidsskr Nor Laegeforen. 1981 Oct 20;101(29):1648-50.
4
[Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations].[阻塞性通气障碍中茶碱制剂的治疗优化。3. 用简单药代动力学方法预测茶碱清除率及比较各种缓释茶碱制剂的生物利用度]
Prax Klin Pneumol. 1983 Mar;37(3):99-108.
5
[Treatment of obstructive respiratory disorders using a new theophylline retard preparation].[使用新型缓释茶碱制剂治疗阻塞性呼吸障碍]
ZFA (Stuttgart). 1982 Jun 20;58(17):974-8.
6
[Measure out oral theophylline exactly. Also determine theophylline levels in clinical practice].精确测量口服氨茶碱。同时在临床实践中测定氨茶碱水平。
Fortschr Med. 1982 Jan 28;100(4):150.
7
8
Theophylline levels in COPD exacerbations.慢性阻塞性肺疾病急性加重期的茶碱水平
Am J Emerg Med. 1991 Mar;9(2):203-4. doi: 10.1016/0735-6757(91)90198-s.
9
The pendulum swings again. Toward a rational use of theophylline.钟摆再次摆动。朝着茶碱的合理使用方向发展。
Chest. 1985 Mar;87(3):280-2. doi: 10.1378/chest.87.3.280.
10
Oral mexiletine-theophylline interaction.口服美西律 - 茶碱相互作用。
Int J Cardiol. 1987 Nov;17(2):227-8. doi: 10.1016/0167-5273(87)90138-0.
引用本文的文献
1
A "Single-Use" Ceramic-Based Electrochemical Sensor Chip Using Molecularly Imprinted Carbon Paste Electrode.一种使用分子印迹碳糊电极的“一次性”陶瓷基电化学传感器芯片。
Sensors (Basel). 2020 Oct 16;20(20):5847. doi: 10.3390/s20205847.
2
Pharmacokinetic optimisation of asthma treatment.哮喘治疗的药代动力学优化
Clin Pharmacokinet. 1994 May;26(5):396-418. doi: 10.2165/00003088-199426050-00006.
3
The effect of respiratory disorders on clinical pharmacokinetic variables.呼吸系统疾病对临床药代动力学变量的影响。
Clin Pharmacokinet. 1990 Dec;19(6):462-90. doi: 10.2165/00003088-199019060-00004.
4
Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.哮喘和囊性纤维化患者中茶碱血清蛋白结合的变异性。
Br J Clin Pharmacol. 1992 Jun;33(6):653-6. doi: 10.1111/j.1365-2125.1992.tb04096.x.
本文引用的文献
1
Dose-dependency of theophylline clearance and protein binding.茶碱清除率及蛋白结合的剂量依赖性。
Thorax. 1981 May;36(5):382-6. doi: 10.1136/thx.36.5.382.
2
Factors influencing theophylline serum protein binding.
Clin Pharmacol Ther. 1982 Oct;32(4):490-6. doi: 10.1038/clpt.1982.193.
3
Determinants of the plasma protein binding of theophylline in health.健康状态下茶碱血浆蛋白结合的决定因素。
Br J Clin Pharmacol. 1983 Apr;15(4):399-405. doi: 10.1111/j.1365-2125.1983.tb01521.x.
4
Free and total plasma theophylline concentrations in chronic airflow obstruction.慢性气流阻塞患者血浆中游离和总茶碱浓度
Thorax. 1984 May;39(5):352-5. doi: 10.1136/thx.39.5.352.
5
Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.唾液浓度能否预测血浆中游离茶碱的浓度？重新审视的一个问题。
Br J Clin Pharmacol. 1984 Jan;17(1):9-14. doi: 10.1111/j.1365-2125.1984.tb04991.x.
6
Binding of theophylline and its metabolites to human plasma proteins.茶碱及其代谢产物与人血浆蛋白的结合
Br J Clin Pharmacol. 1983 Nov;16(5):573-4. doi: 10.1111/j.1365-2125.1983.tb02220.x.
7
Lipid-protein interactions: NMR study of melittin and its binding to lysophosphatidylcholine.脂类-蛋白质相互作用：蜂毒肽及其与溶血磷脂酰胆碱结合的核磁共振研究
Biochim Biophys Acta. 1979 Apr 19;552(3):531-4. doi: 10.1016/0005-2736(79)90197-4.
Zotero 插件